UPLOAD Filing
Inhibitor Therapeutics, Inc.
Date: Sept. 15, 2025 · CIK: 0001042418 · Accession: 0000000000-25-009975
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-13467
Letter
Re: Inhibitor Therapeutics, Inc. Form 10-K for the Year Ended December 31, 2024 Filed March 28, 2025 File No. 001-13467 Dear James A. McNulty:
September 15, 2025
James A. McNulty Interim Chief Financial Officer Inhibitor Therapeutics, Inc. 3014 W. Palmira Avenue Suite 302 Tampa, FL 33629
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 15, 2025 James A. McNulty Interim Chief Financial Officer Inhibitor Therapeutics, Inc. 3014 W. Palmira Avenue Suite 302 Tampa, FL 33629 Re: Inhibitor Therapeutics, Inc. Form 10-K for the Year Ended December 31, 2024 Filed March 28, 2025 File No. 001-13467 Dear James A. McNulty: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>